Global Cannabis Pharmaceuticals Market Growth 2026-2032
The global Cannabis Pharmaceuticals market size is predicted to grow from US$ 1451 million in 2025 to US$ 3639 million in 2032; it is expected to grow at a CAGR of 14.3% from 2026 to 2032.
Cannabis pharmaceuticals refers to the development and sale of pharmaceutical drugs or medicines with compounds of cannabis plants acting as key components. The plant belongs to the Cannabaceae family of flowering plants and produces a highly popular psychoactive drug called marijuana or cannabis. The plant is indigenous to South and Central Asia. It is widely used as a recreational drug. However, in recent times, the pharmaceutical industry has invested heavily in exploring the plant and its components for their medicinal attributes. Two of the most well-researched and popular components are cannabidiol (CBD) and tetrahydrocannabinol (THC) since they are known to exhibit several therapeutic effects. Cannabis pharmaceuticals deal with exploring a combination of cannabinoids and studying their impact on diseases or health conditions under a controlled environment and in the guidance of a licensed supervisor such as a medical practitioner. Medicines produced using cannabis are available in several forms including sprays, capsules, and tablets. The medicines cannot be rolled out in the commercial market without receiving necessary approvals from regulatory bodies.
United States market for Cannabis Pharmaceuticals is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Cannabis Pharmaceuticals is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Cannabis Pharmaceuticals is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Cannabis Pharmaceuticals players cover Cronos Group, Jazz Pharmaceuticals, Elixinol Wellness, Trulieve, Tilray Brands, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Cannabis Pharmaceuticals Industry Forecast” looks at past sales and reviews total world Cannabis Pharmaceuticals sales in 2025, providing a comprehensive analysis by region and market sector of projected Cannabis Pharmaceuticals sales for 2026 through 2032. With Cannabis Pharmaceuticals sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cannabis Pharmaceuticals industry.
This Insight Report provides a comprehensive analysis of the global Cannabis Pharmaceuticals landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cannabis Pharmaceuticals portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cannabis Pharmaceuticals market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cannabis Pharmaceuticals and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cannabis Pharmaceuticals.
This report presents a comprehensive overview, market shares, and growth opportunities of Cannabis Pharmaceuticals market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Cannabis Pharmaceuticals market?
What factors are driving Cannabis Pharmaceuticals market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Cannabis Pharmaceuticals market opportunities vary by end market size?
How does Cannabis Pharmaceuticals break out by Type, by Application?
The report requires updating with new data and is sent in 48 hours after order is placed.
Cannabis pharmaceuticals refers to the development and sale of pharmaceutical drugs or medicines with compounds of cannabis plants acting as key components. The plant belongs to the Cannabaceae family of flowering plants and produces a highly popular psychoactive drug called marijuana or cannabis. The plant is indigenous to South and Central Asia. It is widely used as a recreational drug. However, in recent times, the pharmaceutical industry has invested heavily in exploring the plant and its components for their medicinal attributes. Two of the most well-researched and popular components are cannabidiol (CBD) and tetrahydrocannabinol (THC) since they are known to exhibit several therapeutic effects. Cannabis pharmaceuticals deal with exploring a combination of cannabinoids and studying their impact on diseases or health conditions under a controlled environment and in the guidance of a licensed supervisor such as a medical practitioner. Medicines produced using cannabis are available in several forms including sprays, capsules, and tablets. The medicines cannot be rolled out in the commercial market without receiving necessary approvals from regulatory bodies.
United States market for Cannabis Pharmaceuticals is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Cannabis Pharmaceuticals is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Cannabis Pharmaceuticals is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Cannabis Pharmaceuticals players cover Cronos Group, Jazz Pharmaceuticals, Elixinol Wellness, Trulieve, Tilray Brands, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Cannabis Pharmaceuticals Industry Forecast” looks at past sales and reviews total world Cannabis Pharmaceuticals sales in 2025, providing a comprehensive analysis by region and market sector of projected Cannabis Pharmaceuticals sales for 2026 through 2032. With Cannabis Pharmaceuticals sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cannabis Pharmaceuticals industry.
This Insight Report provides a comprehensive analysis of the global Cannabis Pharmaceuticals landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cannabis Pharmaceuticals portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cannabis Pharmaceuticals market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cannabis Pharmaceuticals and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cannabis Pharmaceuticals.
This report presents a comprehensive overview, market shares, and growth opportunities of Cannabis Pharmaceuticals market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Sprays
- Capsules
- Tablets
- Others
- Pharmacies
- Hospitals
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Cronos Group
- Jazz Pharmaceuticals
- Elixinol Wellness
- Trulieve
- Tilray Brands, Inc.
- Cansortium Inc.
- Aurora Cannabis
- Canopy Growth
- Cresco Labs
- Organigram
What is the 10-year outlook for the global Cannabis Pharmaceuticals market?
What factors are driving Cannabis Pharmaceuticals market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Cannabis Pharmaceuticals market opportunities vary by end market size?
How does Cannabis Pharmaceuticals break out by Type, by Application?
The report requires updating with new data and is sent in 48 hours after order is placed.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cannabis Pharmaceuticals Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Cannabis Pharmaceuticals by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Cannabis Pharmaceuticals by Country/Region, 2021, 2025 & 2032
2.2 Cannabis Pharmaceuticals Segment by Type
2.2.1 Sprays
2.2.2 Capsules
2.2.3 Tablets
2.2.4 Others
2.2.5 Cannabis Pharmaceuticals Sales by Type
2.2.5.1 Global Cannabis Pharmaceuticals Sales Market Share by Type (2021-2026)
2.2.5.2 Global Cannabis Pharmaceuticals Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Cannabis Pharmaceuticals Sale Price by Type (2021-2026)
2.3 Cannabis Pharmaceuticals Segment by Application
2.3.1 Pharmacies
2.3.2 Hospitals
2.3.3 Others
2.3.4 Cannabis Pharmaceuticals Sales by Application
2.3.4.1 Global Cannabis Pharmaceuticals Sale Market Share by Application (2021-2026)
2.3.4.2 Global Cannabis Pharmaceuticals Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Cannabis Pharmaceuticals Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Cannabis Pharmaceuticals Breakdown Data by Company
3.1.1 Global Cannabis Pharmaceuticals Annual Sales by Company (2021-2026)
3.1.2 Global Cannabis Pharmaceuticals Sales Market Share by Company (2021-2026)
3.2 Global Cannabis Pharmaceuticals Annual Revenue by Company (2021-2026)
3.2.1 Global Cannabis Pharmaceuticals Revenue by Company (2021-2026)
3.2.2 Global Cannabis Pharmaceuticals Revenue Market Share by Company (2021-2026)
3.3 Global Cannabis Pharmaceuticals Sale Price by Company
3.4 Key Manufacturers Cannabis Pharmaceuticals Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Cannabis Pharmaceuticals Product Location Distribution
3.4.2 Players Cannabis Pharmaceuticals Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CANNABIS PHARMACEUTICALS BY GEOGRAPHIC REGION
4.1 World Historic Cannabis Pharmaceuticals Market Size by Geographic Region (2021-2026)
4.1.1 Global Cannabis Pharmaceuticals Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Cannabis Pharmaceuticals Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Cannabis Pharmaceuticals Market Size by Country/Region (2021-2026)
4.2.1 Global Cannabis Pharmaceuticals Annual Sales by Country/Region (2021-2026)
4.2.2 Global Cannabis Pharmaceuticals Annual Revenue by Country/Region (2021-2026)
4.3 Americas Cannabis Pharmaceuticals Sales Growth
4.4 APAC Cannabis Pharmaceuticals Sales Growth
4.5 Europe Cannabis Pharmaceuticals Sales Growth
4.6 Middle East & Africa Cannabis Pharmaceuticals Sales Growth
5 AMERICAS
5.1 Americas Cannabis Pharmaceuticals Sales by Country
5.1.1 Americas Cannabis Pharmaceuticals Sales by Country (2021-2026)
5.1.2 Americas Cannabis Pharmaceuticals Revenue by Country (2021-2026)
5.2 Americas Cannabis Pharmaceuticals Sales by Type (2021-2026)
5.3 Americas Cannabis Pharmaceuticals Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cannabis Pharmaceuticals Sales by Region
6.1.1 APAC Cannabis Pharmaceuticals Sales by Region (2021-2026)
6.1.2 APAC Cannabis Pharmaceuticals Revenue by Region (2021-2026)
6.2 APAC Cannabis Pharmaceuticals Sales by Type (2021-2026)
6.3 APAC Cannabis Pharmaceuticals Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Cannabis Pharmaceuticals by Country
7.1.1 Europe Cannabis Pharmaceuticals Sales by Country (2021-2026)
7.1.2 Europe Cannabis Pharmaceuticals Revenue by Country (2021-2026)
7.2 Europe Cannabis Pharmaceuticals Sales by Type (2021-2026)
7.3 Europe Cannabis Pharmaceuticals Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cannabis Pharmaceuticals by Country
8.1.1 Middle East & Africa Cannabis Pharmaceuticals Sales by Country (2021-2026)
8.1.2 Middle East & Africa Cannabis Pharmaceuticals Revenue by Country (2021-2026)
8.2 Middle East & Africa Cannabis Pharmaceuticals Sales by Type (2021-2026)
8.3 Middle East & Africa Cannabis Pharmaceuticals Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Cannabis Pharmaceuticals
10.3 Manufacturing Process Analysis of Cannabis Pharmaceuticals
10.4 Industry Chain Structure of Cannabis Pharmaceuticals
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Cannabis Pharmaceuticals Distributors
11.3 Cannabis Pharmaceuticals Customer
12 WORLD FORECAST REVIEW FOR CANNABIS PHARMACEUTICALS BY GEOGRAPHIC REGION
12.1 Global Cannabis Pharmaceuticals Market Size Forecast by Region
12.1.1 Global Cannabis Pharmaceuticals Forecast by Region (2027-2032)
12.1.2 Global Cannabis Pharmaceuticals Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Cannabis Pharmaceuticals Forecast by Type (2027-2032)
12.7 Global Cannabis Pharmaceuticals Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Cronos Group
13.1.1 Cronos Group Company Information
13.1.2 Cronos Group Cannabis Pharmaceuticals Product Portfolios and Specifications
13.1.3 Cronos Group Cannabis Pharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Cronos Group Main Business Overview
13.1.5 Cronos Group Latest Developments
13.2 Jazz Pharmaceuticals
13.2.1 Jazz Pharmaceuticals Company Information
13.2.2 Jazz Pharmaceuticals Cannabis Pharmaceuticals Product Portfolios and Specifications
13.2.3 Jazz Pharmaceuticals Cannabis Pharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Jazz Pharmaceuticals Main Business Overview
13.2.5 Jazz Pharmaceuticals Latest Developments
13.3 Elixinol Wellness
13.3.1 Elixinol Wellness Company Information
13.3.2 Elixinol Wellness Cannabis Pharmaceuticals Product Portfolios and Specifications
13.3.3 Elixinol Wellness Cannabis Pharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Elixinol Wellness Main Business Overview
13.3.5 Elixinol Wellness Latest Developments
13.4 Trulieve
13.4.1 Trulieve Company Information
13.4.2 Trulieve Cannabis Pharmaceuticals Product Portfolios and Specifications
13.4.3 Trulieve Cannabis Pharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Trulieve Main Business Overview
13.4.5 Trulieve Latest Developments
13.5 Tilray Brands, Inc.
13.5.1 Tilray Brands, Inc. Company Information
13.5.2 Tilray Brands, Inc. Cannabis Pharmaceuticals Product Portfolios and Specifications
13.5.3 Tilray Brands, Inc. Cannabis Pharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Tilray Brands, Inc. Main Business Overview
13.5.5 Tilray Brands, Inc. Latest Developments
13.6 Cansortium Inc.
13.6.1 Cansortium Inc. Company Information
13.6.2 Cansortium Inc. Cannabis Pharmaceuticals Product Portfolios and Specifications
13.6.3 Cansortium Inc. Cannabis Pharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Cansortium Inc. Main Business Overview
13.6.5 Cansortium Inc. Latest Developments
13.7 Aurora Cannabis
13.7.1 Aurora Cannabis Company Information
13.7.2 Aurora Cannabis Cannabis Pharmaceuticals Product Portfolios and Specifications
13.7.3 Aurora Cannabis Cannabis Pharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Aurora Cannabis Main Business Overview
13.7.5 Aurora Cannabis Latest Developments
13.8 Canopy Growth
13.8.1 Canopy Growth Company Information
13.8.2 Canopy Growth Cannabis Pharmaceuticals Product Portfolios and Specifications
13.8.3 Canopy Growth Cannabis Pharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Canopy Growth Main Business Overview
13.8.5 Canopy Growth Latest Developments
13.9 Cresco Labs
13.9.1 Cresco Labs Company Information
13.9.2 Cresco Labs Cannabis Pharmaceuticals Product Portfolios and Specifications
13.9.3 Cresco Labs Cannabis Pharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Cresco Labs Main Business Overview
13.9.5 Cresco Labs Latest Developments
13.10 Organigram
13.10.1 Organigram Company Information
13.10.2 Organigram Cannabis Pharmaceuticals Product Portfolios and Specifications
13.10.3 Organigram Cannabis Pharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Organigram Main Business Overview
13.10.5 Organigram Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cannabis Pharmaceuticals Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Cannabis Pharmaceuticals by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Cannabis Pharmaceuticals by Country/Region, 2021, 2025 & 2032
2.2 Cannabis Pharmaceuticals Segment by Type
2.2.1 Sprays
2.2.2 Capsules
2.2.3 Tablets
2.2.4 Others
2.2.5 Cannabis Pharmaceuticals Sales by Type
2.2.5.1 Global Cannabis Pharmaceuticals Sales Market Share by Type (2021-2026)
2.2.5.2 Global Cannabis Pharmaceuticals Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Cannabis Pharmaceuticals Sale Price by Type (2021-2026)
2.3 Cannabis Pharmaceuticals Segment by Application
2.3.1 Pharmacies
2.3.2 Hospitals
2.3.3 Others
2.3.4 Cannabis Pharmaceuticals Sales by Application
2.3.4.1 Global Cannabis Pharmaceuticals Sale Market Share by Application (2021-2026)
2.3.4.2 Global Cannabis Pharmaceuticals Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Cannabis Pharmaceuticals Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Cannabis Pharmaceuticals Breakdown Data by Company
3.1.1 Global Cannabis Pharmaceuticals Annual Sales by Company (2021-2026)
3.1.2 Global Cannabis Pharmaceuticals Sales Market Share by Company (2021-2026)
3.2 Global Cannabis Pharmaceuticals Annual Revenue by Company (2021-2026)
3.2.1 Global Cannabis Pharmaceuticals Revenue by Company (2021-2026)
3.2.2 Global Cannabis Pharmaceuticals Revenue Market Share by Company (2021-2026)
3.3 Global Cannabis Pharmaceuticals Sale Price by Company
3.4 Key Manufacturers Cannabis Pharmaceuticals Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Cannabis Pharmaceuticals Product Location Distribution
3.4.2 Players Cannabis Pharmaceuticals Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CANNABIS PHARMACEUTICALS BY GEOGRAPHIC REGION
4.1 World Historic Cannabis Pharmaceuticals Market Size by Geographic Region (2021-2026)
4.1.1 Global Cannabis Pharmaceuticals Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Cannabis Pharmaceuticals Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Cannabis Pharmaceuticals Market Size by Country/Region (2021-2026)
4.2.1 Global Cannabis Pharmaceuticals Annual Sales by Country/Region (2021-2026)
4.2.2 Global Cannabis Pharmaceuticals Annual Revenue by Country/Region (2021-2026)
4.3 Americas Cannabis Pharmaceuticals Sales Growth
4.4 APAC Cannabis Pharmaceuticals Sales Growth
4.5 Europe Cannabis Pharmaceuticals Sales Growth
4.6 Middle East & Africa Cannabis Pharmaceuticals Sales Growth
5 AMERICAS
5.1 Americas Cannabis Pharmaceuticals Sales by Country
5.1.1 Americas Cannabis Pharmaceuticals Sales by Country (2021-2026)
5.1.2 Americas Cannabis Pharmaceuticals Revenue by Country (2021-2026)
5.2 Americas Cannabis Pharmaceuticals Sales by Type (2021-2026)
5.3 Americas Cannabis Pharmaceuticals Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cannabis Pharmaceuticals Sales by Region
6.1.1 APAC Cannabis Pharmaceuticals Sales by Region (2021-2026)
6.1.2 APAC Cannabis Pharmaceuticals Revenue by Region (2021-2026)
6.2 APAC Cannabis Pharmaceuticals Sales by Type (2021-2026)
6.3 APAC Cannabis Pharmaceuticals Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Cannabis Pharmaceuticals by Country
7.1.1 Europe Cannabis Pharmaceuticals Sales by Country (2021-2026)
7.1.2 Europe Cannabis Pharmaceuticals Revenue by Country (2021-2026)
7.2 Europe Cannabis Pharmaceuticals Sales by Type (2021-2026)
7.3 Europe Cannabis Pharmaceuticals Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cannabis Pharmaceuticals by Country
8.1.1 Middle East & Africa Cannabis Pharmaceuticals Sales by Country (2021-2026)
8.1.2 Middle East & Africa Cannabis Pharmaceuticals Revenue by Country (2021-2026)
8.2 Middle East & Africa Cannabis Pharmaceuticals Sales by Type (2021-2026)
8.3 Middle East & Africa Cannabis Pharmaceuticals Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Cannabis Pharmaceuticals
10.3 Manufacturing Process Analysis of Cannabis Pharmaceuticals
10.4 Industry Chain Structure of Cannabis Pharmaceuticals
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Cannabis Pharmaceuticals Distributors
11.3 Cannabis Pharmaceuticals Customer
12 WORLD FORECAST REVIEW FOR CANNABIS PHARMACEUTICALS BY GEOGRAPHIC REGION
12.1 Global Cannabis Pharmaceuticals Market Size Forecast by Region
12.1.1 Global Cannabis Pharmaceuticals Forecast by Region (2027-2032)
12.1.2 Global Cannabis Pharmaceuticals Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Cannabis Pharmaceuticals Forecast by Type (2027-2032)
12.7 Global Cannabis Pharmaceuticals Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Cronos Group
13.1.1 Cronos Group Company Information
13.1.2 Cronos Group Cannabis Pharmaceuticals Product Portfolios and Specifications
13.1.3 Cronos Group Cannabis Pharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Cronos Group Main Business Overview
13.1.5 Cronos Group Latest Developments
13.2 Jazz Pharmaceuticals
13.2.1 Jazz Pharmaceuticals Company Information
13.2.2 Jazz Pharmaceuticals Cannabis Pharmaceuticals Product Portfolios and Specifications
13.2.3 Jazz Pharmaceuticals Cannabis Pharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Jazz Pharmaceuticals Main Business Overview
13.2.5 Jazz Pharmaceuticals Latest Developments
13.3 Elixinol Wellness
13.3.1 Elixinol Wellness Company Information
13.3.2 Elixinol Wellness Cannabis Pharmaceuticals Product Portfolios and Specifications
13.3.3 Elixinol Wellness Cannabis Pharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Elixinol Wellness Main Business Overview
13.3.5 Elixinol Wellness Latest Developments
13.4 Trulieve
13.4.1 Trulieve Company Information
13.4.2 Trulieve Cannabis Pharmaceuticals Product Portfolios and Specifications
13.4.3 Trulieve Cannabis Pharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Trulieve Main Business Overview
13.4.5 Trulieve Latest Developments
13.5 Tilray Brands, Inc.
13.5.1 Tilray Brands, Inc. Company Information
13.5.2 Tilray Brands, Inc. Cannabis Pharmaceuticals Product Portfolios and Specifications
13.5.3 Tilray Brands, Inc. Cannabis Pharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Tilray Brands, Inc. Main Business Overview
13.5.5 Tilray Brands, Inc. Latest Developments
13.6 Cansortium Inc.
13.6.1 Cansortium Inc. Company Information
13.6.2 Cansortium Inc. Cannabis Pharmaceuticals Product Portfolios and Specifications
13.6.3 Cansortium Inc. Cannabis Pharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Cansortium Inc. Main Business Overview
13.6.5 Cansortium Inc. Latest Developments
13.7 Aurora Cannabis
13.7.1 Aurora Cannabis Company Information
13.7.2 Aurora Cannabis Cannabis Pharmaceuticals Product Portfolios and Specifications
13.7.3 Aurora Cannabis Cannabis Pharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Aurora Cannabis Main Business Overview
13.7.5 Aurora Cannabis Latest Developments
13.8 Canopy Growth
13.8.1 Canopy Growth Company Information
13.8.2 Canopy Growth Cannabis Pharmaceuticals Product Portfolios and Specifications
13.8.3 Canopy Growth Cannabis Pharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Canopy Growth Main Business Overview
13.8.5 Canopy Growth Latest Developments
13.9 Cresco Labs
13.9.1 Cresco Labs Company Information
13.9.2 Cresco Labs Cannabis Pharmaceuticals Product Portfolios and Specifications
13.9.3 Cresco Labs Cannabis Pharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Cresco Labs Main Business Overview
13.9.5 Cresco Labs Latest Developments
13.10 Organigram
13.10.1 Organigram Company Information
13.10.2 Organigram Cannabis Pharmaceuticals Product Portfolios and Specifications
13.10.3 Organigram Cannabis Pharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Organigram Main Business Overview
13.10.5 Organigram Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Cannabis Pharmaceuticals Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Cannabis Pharmaceuticals Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Sprays
Table 4. Major Players of Capsules
Table 5. Major Players ofTablets
Table 6. Major Players of Others
Table 7. Global Cannabis Pharmaceuticals Sales by Type (2021-2026) & (kg)
Table 8. Global Cannabis Pharmaceuticals Sales Market Share by Type (2021-2026)
Table 9. Global Cannabis Pharmaceuticals Revenue by Type (2021-2026) & ($ million)
Table 10. Global Cannabis Pharmaceuticals Revenue Market Share by Type (2021-2026)
Table 11. Global Cannabis Pharmaceuticals Sale Price by Type (2021-2026) & (US$/g)
Table 12. Global Cannabis Pharmaceuticals Sale by Application (2021-2026) & (kg)
Table 13. Global Cannabis Pharmaceuticals Sale Market Share by Application (2021-2026)
Table 14. Global Cannabis Pharmaceuticals Revenue by Application (2021-2026) & ($ million)
Table 15. Global Cannabis Pharmaceuticals Revenue Market Share by Application (2021-2026)
Table 16. Global Cannabis Pharmaceuticals Sale Price by Application (2021-2026) & (US$/g)
Table 17. Global Cannabis Pharmaceuticals Sales by Company (2021-2026) & (kg)
Table 18. Global Cannabis Pharmaceuticals Sales Market Share by Company (2021-2026)
Table 19. Global Cannabis Pharmaceuticals Revenue by Company (2021-2026) & ($ millions)
Table 20. Global Cannabis Pharmaceuticals Revenue Market Share by Company (2021-2026)
Table 21. Global Cannabis Pharmaceuticals Sale Price by Company (2021-2026) & (US$/g)
Table 22. Key Manufacturers Cannabis Pharmaceuticals Producing Area Distribution and Sales Area
Table 23. Players Cannabis Pharmaceuticals Products Offered
Table 24. Cannabis Pharmaceuticals Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Cannabis Pharmaceuticals Sales by Geographic Region (2021-2026) & (kg)
Table 28. Global Cannabis Pharmaceuticals Sales Market Share Geographic Region (2021-2026)
Table 29. Global Cannabis Pharmaceuticals Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global Cannabis Pharmaceuticals Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global Cannabis Pharmaceuticals Sales by Country/Region (2021-2026) & (kg)
Table 32. Global Cannabis Pharmaceuticals Sales Market Share by Country/Region (2021-2026)
Table 33. Global Cannabis Pharmaceuticals Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Cannabis Pharmaceuticals Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Cannabis Pharmaceuticals Sales by Country (2021-2026) & (kg)
Table 36. Americas Cannabis Pharmaceuticals Sales Market Share by Country (2021-2026)
Table 37. Americas Cannabis Pharmaceuticals Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas Cannabis Pharmaceuticals Sales by Type (2021-2026) & (kg)
Table 39. Americas Cannabis Pharmaceuticals Sales by Application (2021-2026) & (kg)
Table 40. APAC Cannabis Pharmaceuticals Sales by Region (2021-2026) & (kg)
Table 41. APAC Cannabis Pharmaceuticals Sales Market Share by Region (2021-2026)
Table 42. APAC Cannabis Pharmaceuticals Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC Cannabis Pharmaceuticals Sales by Type (2021-2026) & (kg)
Table 44. APAC Cannabis Pharmaceuticals Sales by Application (2021-2026) & (kg)
Table 45. Europe Cannabis Pharmaceuticals Sales by Country (2021-2026) & (kg)
Table 46. Europe Cannabis Pharmaceuticals Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe Cannabis Pharmaceuticals Sales by Type (2021-2026) & (kg)
Table 48. Europe Cannabis Pharmaceuticals Sales by Application (2021-2026) & (kg)
Table 49. Middle East & Africa Cannabis Pharmaceuticals Sales by Country (2021-2026) & (kg)
Table 50. Middle East & Africa Cannabis Pharmaceuticals Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa Cannabis Pharmaceuticals Sales by Type (2021-2026) & (kg)
Table 52. Middle East & Africa Cannabis Pharmaceuticals Sales by Application (2021-2026) & (kg)
Table 53. Key Market Drivers & Growth Opportunities of Cannabis Pharmaceuticals
Table 54. Key Market Challenges & Risks of Cannabis Pharmaceuticals
Table 55. Key Industry Trends of Cannabis Pharmaceuticals
Table 56. Cannabis Pharmaceuticals Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Cannabis Pharmaceuticals Distributors List
Table 59. Cannabis Pharmaceuticals Customer List
Table 60. Global Cannabis Pharmaceuticals Sales Forecast by Region (2027-2032) & (kg)
Table 61. Global Cannabis Pharmaceuticals Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas Cannabis Pharmaceuticals Sales Forecast by Country (2027-2032) & (kg)
Table 63. Americas Cannabis Pharmaceuticals Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC Cannabis Pharmaceuticals Sales Forecast by Region (2027-2032) & (kg)
Table 65. APAC Cannabis Pharmaceuticals Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe Cannabis Pharmaceuticals Sales Forecast by Country (2027-2032) & (kg)
Table 67. Europe Cannabis Pharmaceuticals Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa Cannabis Pharmaceuticals Sales Forecast by Country (2027-2032) & (kg)
Table 69. Middle East & Africa Cannabis Pharmaceuticals Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global Cannabis Pharmaceuticals Sales Forecast by Type (2027-2032) & (kg)
Table 71. Global Cannabis Pharmaceuticals Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global Cannabis Pharmaceuticals Sales Forecast by Application (2027-2032) & (kg)
Table 73. Global Cannabis Pharmaceuticals Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. Cronos Group Basic Information, Cannabis Pharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 75. Cronos Group Cannabis Pharmaceuticals Product Portfolios and Specifications
Table 76. Cronos Group Cannabis Pharmaceuticals Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 77. Cronos Group Main Business
Table 78. Cronos Group Latest Developments
Table 79. Jazz Pharmaceuticals Basic Information, Cannabis Pharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 80. Jazz Pharmaceuticals Cannabis Pharmaceuticals Product Portfolios and Specifications
Table 81. Jazz Pharmaceuticals Cannabis Pharmaceuticals Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 82. Jazz Pharmaceuticals Main Business
Table 83. Jazz Pharmaceuticals Latest Developments
Table 84. Elixinol Wellness Basic Information, Cannabis Pharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 85. Elixinol Wellness Cannabis Pharmaceuticals Product Portfolios and Specifications
Table 86. Elixinol Wellness Cannabis Pharmaceuticals Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 87. Elixinol Wellness Main Business
Table 88. Elixinol Wellness Latest Developments
Table 89. Trulieve Basic Information, Cannabis Pharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 90. Trulieve Cannabis Pharmaceuticals Product Portfolios and Specifications
Table 91. Trulieve Cannabis Pharmaceuticals Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 92. Trulieve Main Business
Table 93. Trulieve Latest Developments
Table 94. Tilray Brands, Inc. Basic Information, Cannabis Pharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 95. Tilray Brands, Inc. Cannabis Pharmaceuticals Product Portfolios and Specifications
Table 96. Tilray Brands, Inc. Cannabis Pharmaceuticals Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 97. Tilray Brands, Inc. Main Business
Table 98. Tilray Brands, Inc. Latest Developments
Table 99. Cansortium Inc. Basic Information, Cannabis Pharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 100. Cansortium Inc. Cannabis Pharmaceuticals Product Portfolios and Specifications
Table 101. Cansortium Inc. Cannabis Pharmaceuticals Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 102. Cansortium Inc. Main Business
Table 103. Cansortium Inc. Latest Developments
Table 104. Aurora Cannabis Basic Information, Cannabis Pharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 105. Aurora Cannabis Cannabis Pharmaceuticals Product Portfolios and Specifications
Table 106. Aurora Cannabis Cannabis Pharmaceuticals Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 107. Aurora Cannabis Main Business
Table 108. Aurora Cannabis Latest Developments
Table 109. Canopy Growth Basic Information, Cannabis Pharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 110. Canopy Growth Cannabis Pharmaceuticals Product Portfolios and Specifications
Table 111. Canopy Growth Cannabis Pharmaceuticals Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 112. Canopy Growth Main Business
Table 113. Canopy Growth Latest Developments
Table 114. Cresco Labs Basic Information, Cannabis Pharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 115. Cresco Labs Cannabis Pharmaceuticals Product Portfolios and Specifications
Table 116. Cresco Labs Cannabis Pharmaceuticals Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 117. Cresco Labs Main Business
Table 118. Cresco Labs Latest Developments
Table 119. Organigram Basic Information, Cannabis Pharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 120. Organigram Cannabis Pharmaceuticals Product Portfolios and Specifications
Table 121. Organigram Cannabis Pharmaceuticals Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 122. Organigram Main Business
Table 123. Organigram Latest Developments
Table 1. Cannabis Pharmaceuticals Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Cannabis Pharmaceuticals Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Sprays
Table 4. Major Players of Capsules
Table 5. Major Players ofTablets
Table 6. Major Players of Others
Table 7. Global Cannabis Pharmaceuticals Sales by Type (2021-2026) & (kg)
Table 8. Global Cannabis Pharmaceuticals Sales Market Share by Type (2021-2026)
Table 9. Global Cannabis Pharmaceuticals Revenue by Type (2021-2026) & ($ million)
Table 10. Global Cannabis Pharmaceuticals Revenue Market Share by Type (2021-2026)
Table 11. Global Cannabis Pharmaceuticals Sale Price by Type (2021-2026) & (US$/g)
Table 12. Global Cannabis Pharmaceuticals Sale by Application (2021-2026) & (kg)
Table 13. Global Cannabis Pharmaceuticals Sale Market Share by Application (2021-2026)
Table 14. Global Cannabis Pharmaceuticals Revenue by Application (2021-2026) & ($ million)
Table 15. Global Cannabis Pharmaceuticals Revenue Market Share by Application (2021-2026)
Table 16. Global Cannabis Pharmaceuticals Sale Price by Application (2021-2026) & (US$/g)
Table 17. Global Cannabis Pharmaceuticals Sales by Company (2021-2026) & (kg)
Table 18. Global Cannabis Pharmaceuticals Sales Market Share by Company (2021-2026)
Table 19. Global Cannabis Pharmaceuticals Revenue by Company (2021-2026) & ($ millions)
Table 20. Global Cannabis Pharmaceuticals Revenue Market Share by Company (2021-2026)
Table 21. Global Cannabis Pharmaceuticals Sale Price by Company (2021-2026) & (US$/g)
Table 22. Key Manufacturers Cannabis Pharmaceuticals Producing Area Distribution and Sales Area
Table 23. Players Cannabis Pharmaceuticals Products Offered
Table 24. Cannabis Pharmaceuticals Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Cannabis Pharmaceuticals Sales by Geographic Region (2021-2026) & (kg)
Table 28. Global Cannabis Pharmaceuticals Sales Market Share Geographic Region (2021-2026)
Table 29. Global Cannabis Pharmaceuticals Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global Cannabis Pharmaceuticals Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global Cannabis Pharmaceuticals Sales by Country/Region (2021-2026) & (kg)
Table 32. Global Cannabis Pharmaceuticals Sales Market Share by Country/Region (2021-2026)
Table 33. Global Cannabis Pharmaceuticals Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Cannabis Pharmaceuticals Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Cannabis Pharmaceuticals Sales by Country (2021-2026) & (kg)
Table 36. Americas Cannabis Pharmaceuticals Sales Market Share by Country (2021-2026)
Table 37. Americas Cannabis Pharmaceuticals Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas Cannabis Pharmaceuticals Sales by Type (2021-2026) & (kg)
Table 39. Americas Cannabis Pharmaceuticals Sales by Application (2021-2026) & (kg)
Table 40. APAC Cannabis Pharmaceuticals Sales by Region (2021-2026) & (kg)
Table 41. APAC Cannabis Pharmaceuticals Sales Market Share by Region (2021-2026)
Table 42. APAC Cannabis Pharmaceuticals Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC Cannabis Pharmaceuticals Sales by Type (2021-2026) & (kg)
Table 44. APAC Cannabis Pharmaceuticals Sales by Application (2021-2026) & (kg)
Table 45. Europe Cannabis Pharmaceuticals Sales by Country (2021-2026) & (kg)
Table 46. Europe Cannabis Pharmaceuticals Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe Cannabis Pharmaceuticals Sales by Type (2021-2026) & (kg)
Table 48. Europe Cannabis Pharmaceuticals Sales by Application (2021-2026) & (kg)
Table 49. Middle East & Africa Cannabis Pharmaceuticals Sales by Country (2021-2026) & (kg)
Table 50. Middle East & Africa Cannabis Pharmaceuticals Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa Cannabis Pharmaceuticals Sales by Type (2021-2026) & (kg)
Table 52. Middle East & Africa Cannabis Pharmaceuticals Sales by Application (2021-2026) & (kg)
Table 53. Key Market Drivers & Growth Opportunities of Cannabis Pharmaceuticals
Table 54. Key Market Challenges & Risks of Cannabis Pharmaceuticals
Table 55. Key Industry Trends of Cannabis Pharmaceuticals
Table 56. Cannabis Pharmaceuticals Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Cannabis Pharmaceuticals Distributors List
Table 59. Cannabis Pharmaceuticals Customer List
Table 60. Global Cannabis Pharmaceuticals Sales Forecast by Region (2027-2032) & (kg)
Table 61. Global Cannabis Pharmaceuticals Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas Cannabis Pharmaceuticals Sales Forecast by Country (2027-2032) & (kg)
Table 63. Americas Cannabis Pharmaceuticals Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC Cannabis Pharmaceuticals Sales Forecast by Region (2027-2032) & (kg)
Table 65. APAC Cannabis Pharmaceuticals Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe Cannabis Pharmaceuticals Sales Forecast by Country (2027-2032) & (kg)
Table 67. Europe Cannabis Pharmaceuticals Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa Cannabis Pharmaceuticals Sales Forecast by Country (2027-2032) & (kg)
Table 69. Middle East & Africa Cannabis Pharmaceuticals Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global Cannabis Pharmaceuticals Sales Forecast by Type (2027-2032) & (kg)
Table 71. Global Cannabis Pharmaceuticals Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global Cannabis Pharmaceuticals Sales Forecast by Application (2027-2032) & (kg)
Table 73. Global Cannabis Pharmaceuticals Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. Cronos Group Basic Information, Cannabis Pharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 75. Cronos Group Cannabis Pharmaceuticals Product Portfolios and Specifications
Table 76. Cronos Group Cannabis Pharmaceuticals Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 77. Cronos Group Main Business
Table 78. Cronos Group Latest Developments
Table 79. Jazz Pharmaceuticals Basic Information, Cannabis Pharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 80. Jazz Pharmaceuticals Cannabis Pharmaceuticals Product Portfolios and Specifications
Table 81. Jazz Pharmaceuticals Cannabis Pharmaceuticals Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 82. Jazz Pharmaceuticals Main Business
Table 83. Jazz Pharmaceuticals Latest Developments
Table 84. Elixinol Wellness Basic Information, Cannabis Pharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 85. Elixinol Wellness Cannabis Pharmaceuticals Product Portfolios and Specifications
Table 86. Elixinol Wellness Cannabis Pharmaceuticals Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 87. Elixinol Wellness Main Business
Table 88. Elixinol Wellness Latest Developments
Table 89. Trulieve Basic Information, Cannabis Pharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 90. Trulieve Cannabis Pharmaceuticals Product Portfolios and Specifications
Table 91. Trulieve Cannabis Pharmaceuticals Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 92. Trulieve Main Business
Table 93. Trulieve Latest Developments
Table 94. Tilray Brands, Inc. Basic Information, Cannabis Pharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 95. Tilray Brands, Inc. Cannabis Pharmaceuticals Product Portfolios and Specifications
Table 96. Tilray Brands, Inc. Cannabis Pharmaceuticals Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 97. Tilray Brands, Inc. Main Business
Table 98. Tilray Brands, Inc. Latest Developments
Table 99. Cansortium Inc. Basic Information, Cannabis Pharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 100. Cansortium Inc. Cannabis Pharmaceuticals Product Portfolios and Specifications
Table 101. Cansortium Inc. Cannabis Pharmaceuticals Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 102. Cansortium Inc. Main Business
Table 103. Cansortium Inc. Latest Developments
Table 104. Aurora Cannabis Basic Information, Cannabis Pharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 105. Aurora Cannabis Cannabis Pharmaceuticals Product Portfolios and Specifications
Table 106. Aurora Cannabis Cannabis Pharmaceuticals Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 107. Aurora Cannabis Main Business
Table 108. Aurora Cannabis Latest Developments
Table 109. Canopy Growth Basic Information, Cannabis Pharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 110. Canopy Growth Cannabis Pharmaceuticals Product Portfolios and Specifications
Table 111. Canopy Growth Cannabis Pharmaceuticals Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 112. Canopy Growth Main Business
Table 113. Canopy Growth Latest Developments
Table 114. Cresco Labs Basic Information, Cannabis Pharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 115. Cresco Labs Cannabis Pharmaceuticals Product Portfolios and Specifications
Table 116. Cresco Labs Cannabis Pharmaceuticals Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 117. Cresco Labs Main Business
Table 118. Cresco Labs Latest Developments
Table 119. Organigram Basic Information, Cannabis Pharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 120. Organigram Cannabis Pharmaceuticals Product Portfolios and Specifications
Table 121. Organigram Cannabis Pharmaceuticals Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 122. Organigram Main Business
Table 123. Organigram Latest Developments
LIST OF FIGURES
Figure 1. Picture of Cannabis Pharmaceuticals
Figure 2. Cannabis Pharmaceuticals Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Cannabis Pharmaceuticals Sales Growth Rate 2021-2032 (kg)
Figure 7. Global Cannabis Pharmaceuticals Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Cannabis Pharmaceuticals Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Cannabis Pharmaceuticals Sales Market Share by Country/Region (2025)
Figure 10. Cannabis Pharmaceuticals Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Sprays
Figure 12. Product Picture of Capsules
Figure 13. Product Picture ofTablets
Figure 14. Product Picture of Others
Figure 15. Global Cannabis Pharmaceuticals Sales Market Share by Type in 2026
Figure 16. Global Cannabis Pharmaceuticals Revenue Market Share by Type (2021-2026)
Figure 17. Cannabis Pharmaceuticals Consumed in Pharmacies
Figure 18. Global Cannabis Pharmaceuticals Market: Pharmacies (2021-2026) & (kg)
Figure 19. Cannabis Pharmaceuticals Consumed in Hospitals
Figure 20. Global Cannabis Pharmaceuticals Market: Hospitals (2021-2026) & (kg)
Figure 21. Cannabis Pharmaceuticals Consumed in Others
Figure 22. Global Cannabis Pharmaceuticals Market: Others (2021-2026) & (kg)
Figure 23. Global Cannabis Pharmaceuticals Sale Market Share by Application (2025)
Figure 24. Global Cannabis Pharmaceuticals Revenue Market Share by Application in 2026
Figure 25. Cannabis Pharmaceuticals Sales by Company in 2026 (kg)
Figure 26. Global Cannabis Pharmaceuticals Sales Market Share by Company in 2026
Figure 27. Cannabis Pharmaceuticals Revenue by Company in 2026 ($ millions)
Figure 28. Global Cannabis Pharmaceuticals Revenue Market Share by Company in 2026
Figure 29. Global Cannabis Pharmaceuticals Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global Cannabis Pharmaceuticals Revenue Market Share by Geographic Region in 2026
Figure 31. Americas Cannabis Pharmaceuticals Sales 2021-2026 (kg)
Figure 32. Americas Cannabis Pharmaceuticals Revenue 2021-2026 ($ millions)
Figure 33. APAC Cannabis Pharmaceuticals Sales 2021-2026 (kg)
Figure 34. APAC Cannabis Pharmaceuticals Revenue 2021-2026 ($ millions)
Figure 35. Europe Cannabis Pharmaceuticals Sales 2021-2026 (kg)
Figure 36. Europe Cannabis Pharmaceuticals Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa Cannabis Pharmaceuticals Sales 2021-2026 (kg)
Figure 38. Middle East & Africa Cannabis Pharmaceuticals Revenue 2021-2026 ($ millions)
Figure 39. Americas Cannabis Pharmaceuticals Sales Market Share by Country in 2026
Figure 40. Americas Cannabis Pharmaceuticals Revenue Market Share by Country (2021-2026)
Figure 41. Americas Cannabis Pharmaceuticals Sales Market Share by Type (2021-2026)
Figure 42. Americas Cannabis Pharmaceuticals Sales Market Share by Application (2021-2026)
Figure 43. United States Cannabis Pharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada Cannabis Pharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico Cannabis Pharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil Cannabis Pharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC Cannabis Pharmaceuticals Sales Market Share by Region in 2026
Figure 48. APAC Cannabis Pharmaceuticals Revenue Market Share by Region (2021-2026)
Figure 49. APAC Cannabis Pharmaceuticals Sales Market Share by Type (2021-2026)
Figure 50. APAC Cannabis Pharmaceuticals Sales Market Share by Application (2021-2026)
Figure 51. China Cannabis Pharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan Cannabis Pharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea Cannabis Pharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia Cannabis Pharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 55. India Cannabis Pharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia Cannabis Pharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan Cannabis Pharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe Cannabis Pharmaceuticals Sales Market Share by Country in 2026
Figure 59. Europe Cannabis Pharmaceuticals Revenue Market Share by Country (2021-2026)
Figure 60. Europe Cannabis Pharmaceuticals Sales Market Share by Type (2021-2026)
Figure 61. Europe Cannabis Pharmaceuticals Sales Market Share by Application (2021-2026)
Figure 62. Germany Cannabis Pharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 63. France Cannabis Pharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 64. UK Cannabis Pharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy Cannabis Pharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia Cannabis Pharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa Cannabis Pharmaceuticals Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa Cannabis Pharmaceuticals Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa Cannabis Pharmaceuticals Sales Market Share by Application (2021-2026)
Figure 70. Egypt Cannabis Pharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa Cannabis Pharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel Cannabis Pharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey Cannabis Pharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries Cannabis Pharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Cannabis Pharmaceuticals in 2026
Figure 76. Manufacturing Process Analysis of Cannabis Pharmaceuticals
Figure 77. Industry Chain Structure of Cannabis Pharmaceuticals
Figure 78. Channels of Distribution
Figure 79. Global Cannabis Pharmaceuticals Sales Market Forecast by Region (2027-2032)
Figure 80. Global Cannabis Pharmaceuticals Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global Cannabis Pharmaceuticals Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global Cannabis Pharmaceuticals Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global Cannabis Pharmaceuticals Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global Cannabis Pharmaceuticals Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Cannabis Pharmaceuticals
Figure 2. Cannabis Pharmaceuticals Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Cannabis Pharmaceuticals Sales Growth Rate 2021-2032 (kg)
Figure 7. Global Cannabis Pharmaceuticals Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Cannabis Pharmaceuticals Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Cannabis Pharmaceuticals Sales Market Share by Country/Region (2025)
Figure 10. Cannabis Pharmaceuticals Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Sprays
Figure 12. Product Picture of Capsules
Figure 13. Product Picture ofTablets
Figure 14. Product Picture of Others
Figure 15. Global Cannabis Pharmaceuticals Sales Market Share by Type in 2026
Figure 16. Global Cannabis Pharmaceuticals Revenue Market Share by Type (2021-2026)
Figure 17. Cannabis Pharmaceuticals Consumed in Pharmacies
Figure 18. Global Cannabis Pharmaceuticals Market: Pharmacies (2021-2026) & (kg)
Figure 19. Cannabis Pharmaceuticals Consumed in Hospitals
Figure 20. Global Cannabis Pharmaceuticals Market: Hospitals (2021-2026) & (kg)
Figure 21. Cannabis Pharmaceuticals Consumed in Others
Figure 22. Global Cannabis Pharmaceuticals Market: Others (2021-2026) & (kg)
Figure 23. Global Cannabis Pharmaceuticals Sale Market Share by Application (2025)
Figure 24. Global Cannabis Pharmaceuticals Revenue Market Share by Application in 2026
Figure 25. Cannabis Pharmaceuticals Sales by Company in 2026 (kg)
Figure 26. Global Cannabis Pharmaceuticals Sales Market Share by Company in 2026
Figure 27. Cannabis Pharmaceuticals Revenue by Company in 2026 ($ millions)
Figure 28. Global Cannabis Pharmaceuticals Revenue Market Share by Company in 2026
Figure 29. Global Cannabis Pharmaceuticals Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global Cannabis Pharmaceuticals Revenue Market Share by Geographic Region in 2026
Figure 31. Americas Cannabis Pharmaceuticals Sales 2021-2026 (kg)
Figure 32. Americas Cannabis Pharmaceuticals Revenue 2021-2026 ($ millions)
Figure 33. APAC Cannabis Pharmaceuticals Sales 2021-2026 (kg)
Figure 34. APAC Cannabis Pharmaceuticals Revenue 2021-2026 ($ millions)
Figure 35. Europe Cannabis Pharmaceuticals Sales 2021-2026 (kg)
Figure 36. Europe Cannabis Pharmaceuticals Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa Cannabis Pharmaceuticals Sales 2021-2026 (kg)
Figure 38. Middle East & Africa Cannabis Pharmaceuticals Revenue 2021-2026 ($ millions)
Figure 39. Americas Cannabis Pharmaceuticals Sales Market Share by Country in 2026
Figure 40. Americas Cannabis Pharmaceuticals Revenue Market Share by Country (2021-2026)
Figure 41. Americas Cannabis Pharmaceuticals Sales Market Share by Type (2021-2026)
Figure 42. Americas Cannabis Pharmaceuticals Sales Market Share by Application (2021-2026)
Figure 43. United States Cannabis Pharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada Cannabis Pharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico Cannabis Pharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil Cannabis Pharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC Cannabis Pharmaceuticals Sales Market Share by Region in 2026
Figure 48. APAC Cannabis Pharmaceuticals Revenue Market Share by Region (2021-2026)
Figure 49. APAC Cannabis Pharmaceuticals Sales Market Share by Type (2021-2026)
Figure 50. APAC Cannabis Pharmaceuticals Sales Market Share by Application (2021-2026)
Figure 51. China Cannabis Pharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan Cannabis Pharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea Cannabis Pharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia Cannabis Pharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 55. India Cannabis Pharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia Cannabis Pharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan Cannabis Pharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe Cannabis Pharmaceuticals Sales Market Share by Country in 2026
Figure 59. Europe Cannabis Pharmaceuticals Revenue Market Share by Country (2021-2026)
Figure 60. Europe Cannabis Pharmaceuticals Sales Market Share by Type (2021-2026)
Figure 61. Europe Cannabis Pharmaceuticals Sales Market Share by Application (2021-2026)
Figure 62. Germany Cannabis Pharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 63. France Cannabis Pharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 64. UK Cannabis Pharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy Cannabis Pharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia Cannabis Pharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa Cannabis Pharmaceuticals Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa Cannabis Pharmaceuticals Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa Cannabis Pharmaceuticals Sales Market Share by Application (2021-2026)
Figure 70. Egypt Cannabis Pharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa Cannabis Pharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel Cannabis Pharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey Cannabis Pharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries Cannabis Pharmaceuticals Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Cannabis Pharmaceuticals in 2026
Figure 76. Manufacturing Process Analysis of Cannabis Pharmaceuticals
Figure 77. Industry Chain Structure of Cannabis Pharmaceuticals
Figure 78. Channels of Distribution
Figure 79. Global Cannabis Pharmaceuticals Sales Market Forecast by Region (2027-2032)
Figure 80. Global Cannabis Pharmaceuticals Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global Cannabis Pharmaceuticals Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global Cannabis Pharmaceuticals Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global Cannabis Pharmaceuticals Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global Cannabis Pharmaceuticals Revenue Market Share Forecast by Application (2027-2032)
